Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2008-04-07 | Paul G. Gabos was elected as a Director in November 2002. Mr. Gabos has served as Chief Financial Officer of Lincare Holdings Inc. since June 1997 and previously served as Vice President — Administration for Lincare. Prior to joining Lincare in 1993, Mr. Gabos worked for Coopers & Lybrand and for Dean Witter Reynolds, Inc. Director Compensation table shows total compensation of $120,555 in 2007. |
| 2008-08-22 | See "DIRECTOR COMPENSATION" table for details. |
| 2009-03-24 | Paul G. Gabos (1)(2) 43 Director |
| 2010-03-26 | Paul G. Gabos (1)(2) 44 Director ... Member of the Audit Committee. Compensation for Mr. Gabos is disclosed in the Director Compensation table. |
| 2011-03-25 | Paul G. Gabos (1)(2) 45 Director |
| 2012-03-30 | Paul G. Gabos (1)(2) 46 Director ... Mr. Gabos has served as Chief Financial Officer of Lincare Holdings Inc. ("Lincare") since June 1997 and previously served as Vice President 6 Administration for Lincare. ... MEDNAX's Audit Committee held seven meetings in 2011. Messrs. Gabos, Sosa and Kadre and Ms. Garcia were members of the committee throughout 2011. Mr. Gabos acted as chair of the committee throughout 2011. ... The following table includes all non-employee Directors who served in 2011. ... Paul G. Gabos $ 87,500 $ 96,338 $ d $ 183,838 |
| 2013-03-22 | Paul G. Gabos (1)(2) 47 Director ... Mr. Gabos was elected as a Director in November 2002 ... MEDNAX's Audit Committee held seven meetings in 2012. Messrs. Gabos and Kadre and Dr. Sosa were members of the committee throughout 2012. Mr. Gabos acted as chair of the committee throughout 2012. ... The Board of Directors' policy for awarding restricted stock also applies to each non-employee Director upon his or her initial appointment to the Board of Directors. The grant date fair value of the award will be $200,000 with a three-year vesting period. ... Director Compensation ... Paul G. Gabos $87,500 $97,516 $0 $185,016 |
| 2014-03-21 | Paul G. Gabos (1)(2) 48 Director |
| 2015-03-20 | Paul G. Gabos (1)(2) 49 Director |
| 2015-09-18 | The following table includes all non-employee Directors who served in 2014. Dr. Medel does not earn additional income for his service as a Director. Name: Paul G. Gabos Total Compensation: $220,035 |
| 2016-03-18 | Paul G. Gabos (1)(2) 50 Director ... Total Compensation $220,001 |
| 2017-03-17 | Paul G. Gabos (1)(2) 51 Director |
| 2018-03-23 | Paul G. Gabos (1)(2) 52 Director |
| 2019-03-29 | Paul G. Gabos (1)(2) 53 Director |
| 2020-07-28 | Paul G. Gabos was elected as a Director in November 2002. Mr. Gabos, who is presently retired, served as Chief Financial Officer of Lincare Holdings Inc. (Lincare), a provider of oxygen and other respiratory therapy services to patients in the home, from June 1997 until December 2012, after its merger with a subsidiary of Linde AG, and prior thereto served as Vice President – Administration for Lincare. ... The Board of Directors has concluded that Mr. Gabos’ qualifications to serve on the Board include his management experience as a senior executive and financial expertise as Chief Financial Officer of a publicly traded healthcare services company and prior thereto as an investment banker with a large national firm. ... The Settlement Agreement provides that, during the Standstill Period, subject to certain exceptions, ... (ii) the Audit Committee will be composed of Ms. Barker and Messrs. Gabos, McEachin and Rucker, with Mr. Gabos as Chair; ... The following table includes all non-employee Directors who served in 2019. ... Paul G. Gabos $ 92,500 $ 127,505 $ 220,005 |
| 2021-03-23 | Paul G. Gabos was elected as a Director in November 2002. Mr. Gabos, who is presently retired, served as Chief Financial Officer of Lincare Holdings Inc. (Lincare), a provider of oxygen and other respiratory therapy services to patients in the home, from June 1997 through December 2012, until its merger with a subsidiary of Linde AG, and prior thereto served as Vice President – Administration for Lincare. |
Data sourced from SEC filings. Last updated: 2026-02-03